Peak Bio, Inc. Deferred Offering Costs
Peak Bio, Inc. had Deferred Offering Costs of $81.58 thousand as of 2020-12-31, per its 10-Q filed 2021-07-26.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2021-07-26
- 2020-12-31: Deferred Offering Costs $81.58K.
| Period end | Deferred Offering Costs |
|---|---|
| 2020-12-31 | $81.58K 10-Q · filed 2021-07-26 |